Related Experiment Videos
Synthesis of peptidoglycan in vivo in methicillin-resistant Staphylococcus aureus
Abstract:
The cell-wall composition and degree of cross-linking of peptidoglycan in a strain of Staphylococcus aureus (strain MR-1) which is highly resistant to methicillin were similar to those of other strains of S. aureus. When the organism was grown in the presence of very low concentrations of methicillin (equivalent to 3 x 10(-4) x minimum growth-inhibitory concentration [MGIC] there was a large decrease in the degree of cross-linking of the peptidoglycan. Increasing concentrations of methicillin (up to 1.25 x 10(-2) x MGIC) caused a further decrease in cross-linkage but thereafter a minimum value was reached. This remained unchanged even after growth of the organisms in much higher concentrations of the antibiotic up to 0.3 x minimum growth-inhibitory concentration. S. aureus MR-1 was able to grow normally for many generations under these conditions and reduction in cross-linkage of peptidoglycan was the only change detected in wall chemistry. Growth in the presence of methicillin (up to 0.3 x MGIC) (or other beta-lactam antibiotics) did not lead to an imbalance in the biosynthesis of peptidoglycan since no soluble polymers were secreted into the growth medium and nucleotide-linked precursors did not accumulate intracellularly. High concentrations of beta-lactam antibiotics (5 x MGIC) were bacteriostatic not bactericidal and this may be related to an apparent deficiency in the endogenous autolytic enzymes of strain MR-1. Studies of the penicillin-binding proteins after growth in the presence of methicillin suggest that one of these proteins remains resistant to very high concentrations of the antibiotic. We propose that this protein acts as the primary transpeptidase responsible for the incorporation of newly synthesised peptidoglycan into the growing wall.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) exhibits reduced peptidoglycan cross-linking when exposed to methicillin. This cell wall alteration allows MRSA to grow, suggesting a key protein remains functional against high antibiotic concentrations.
Area of Science:
- Microbiology
- Biochemistry
- Molecular Biology
Background:
- Staphylococcus aureus is a common pathogen, with methicillin-resistant strains posing significant public health challenges.
- Understanding the cell wall modifications in methicillin-resistant Staphylococcus aureus (MRSA) is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the impact of methicillin on the cell wall composition and peptidoglycan cross-linking in a highly resistant strain of Staphylococcus aureus (MR-1).
- To explore the mechanisms underlying MRSA's resistance and growth in the presence of beta-lactam antibiotics.
Main Methods:
- Comparative analysis of peptidoglycan cross-linking in Staphylococcus aureus MR-1 grown with and without methicillin.
- Assessment of peptidoglycan biosynthesis, precursor accumulation, and autolytic enzyme activity.
- Investigation of penicillin-binding proteins after exposure to methicillin.
Main Results:
- Methicillin exposure, even at low concentrations, significantly decreased peptidoglycan cross-linking in Staphylococcus aureus MR-1.
- The reduction in cross-linking was the primary observed change in cell wall chemistry, without affecting peptidoglycan biosynthesis or precursor levels.
- High concentrations of methicillin were bacteriostatic, potentially due to a deficiency in autolytic enzymes.
- A specific penicillin-binding protein remained resistant to high methicillin concentrations.
Conclusions:
- Reduced peptidoglycan cross-linking is a key adaptation allowing MRSA to grow in the presence of methicillin.
- A methicillin-resistant transpeptidase protein is likely responsible for incorporating new peptidoglycan into the cell wall.
- These findings offer insights into MRSA resistance mechanisms and potential therapeutic targets.